Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
|
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
|---|---|---|---|---|---|---|---|---|---|
| TGCT | rs41299206 | chr10:1120236 | T/C | 1.75E-13 | 133 | 42.03 | 70.63 | 17.1 | KM Plot |
| TGCT | rs41320045 | chr4:154720615 | A/T | 1.65E-5 | 134 | 56.7 | 49.93 | 39.38 | KM Plot |
| TGCT | rs4141937 | chr6:41341253 | G/T | 9.31E-7 | 132 | 45.1 | 25.77 | 11.53 | KM Plot |
| TGCT | rs4147775 | chr5:1816431 | G/C | 5.54E-6 | 134 | 42.27 | 41.97 | 24.73 | KM Plot |
| TGCT | rs414902 | chr17:39365542 | T/G | 7.11E-7 | 133 | 13.17 | 46.03 | 42.1 | KM Plot |
| TGCT | rs41508750 | chr12:129276658 | A/AC | 1.44E-5 | 133 | 29.53 | 44.28 | 42.1 | KM Plot |
| TGCT | rs4246257 | chr12:107062329 | C/T | 0.000103 | 134 | 48.87 | 38.2 | 28.8 | KM Plot |
| TGCT | rs424830 | chr17:39339765 | A/C | 6.24E-7 | 134 | 13.17 | 46.03 | 42.18 | KM Plot |
| TGCT | rs4264754 | chr3:172533919 | T/C | 5.03E-5 | 134 | 42.03 | 41.92 | 47.38 | KM Plot |
| TGCT | rs4275010 | chr5:1798203 | C/T | 4.19E-7 | 132 | 42.27 | 48.4 | 20.6 | KM Plot |
| TGCT | rs4275715 | chr12:107062246 | C/T | 0.000103 | 134 | 48.87 | 38.2 | 28.8 | KM Plot |
| TGCT | rs4277951 | chr5:1798022 | G/T | 4.04E-7 | 133 | 42.27 | 45.83 | 20.6 | KM Plot |
| TGCT | rs4283459 | chr2:54824849 | C/T | 7.1E-5 | 130 | 46.3 | 45.83 | 22.42 | KM Plot |
| TGCT | rs4296838 | chr5:1798410 | G/A | 1.84E-6 | 133 | 42.27 | 48.4 | 19.5 | KM Plot |
| TGCT | rs4296839 | chr5:1798413 | G/A | 1.84E-6 | 133 | 42.27 | 48.4 | 19.5 | KM Plot |